Filippi M, Amato MP, Centonze D, Gallo P, Gasperini C, Inglese M, Patti F, Pozzilli C, Preziosa P, Trojano M (2022) Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion. J Neurol 269:5382–5394. https://doi.org/10.1007/s00415-022-11193-w
Article PubMed PubMed Central Google Scholar
Cobo-Calvo A, Tur C, Otero-Romero S, Carbonell-Mirabent P, Ruiz M, Pappolla A, Alvarez JV, Vidal-Jordana A, Arrambide G, Castilló J, Galan I, Rodríguez Barranco M, Midaglia LS, Nos C, Rodriguez Acevedo B, Zabalza de Torres A, Mongay N, Rio J, Comabella M, Auger C, Sastre-Garriga J, Rovira A, Tintore M, Montalban X (2023) Association of very early treatment initiation with the risk of long-term disability in patients with a first demyelinating event. Neurology 101:e1280–e1292. https://doi.org/10.1212/wnl.0000000000207664
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173. https://doi.org/10.1016/S1474-4422(17)30470-2
Sørensen TL, Frederiksen JL, Brønnum-Hansen H, Petersen HC (1999) Optic neuritis as onset manifestation of multiple sclerosis. Neurology 53:473–478
Filippi M, Preziosa P, Meani A, Dalla Costa G, Mesaros S, Drulovic J, Ivanovic J, Rovira A, Tintorè M, Montalban X, Ciccarelli O, Brownlee W, Miszkiel K, Enzinger C, Khalil M, Barkhof F, Strijbis EMM, Frederiksen JL, Cramer SP, Fainardi E, Amato MP, Gasperini C, Ruggieri S, Martinelli V, Comi G, Rocca MA, de Stefano N, Palace J, Kappos L, Sastre-Garriga J, Yousry T (2022) Performance of the 2017 and 2010 revised mcdonald criteria in predicting ms diagnosis after a clinically isolated syndrome: a MAGNIMS study. Neurology 98:E1–E14. https://doi.org/10.1212/WNL.0000000000013016
Article CAS PubMed Google Scholar
Khalil M, Teunissen CE, Lehmann S, Otto M, Piehl F, Ziemssen T, Bittner S, Sormani MP, Gattringer T, Abu-Rumeileh S, Thebault S, Abdelhak A, Green A, Benkert P, Kappos L, Comabella M, Tumani H, Freedman MS, Petzold A, Blennow K, Zetterberg H, Leppert D, Kuhle J (2024) Neurofilaments as biomarkers in neurological disorders—towards clinical application. Nat Rev Neurol. https://doi.org/10.1038/s41582-024-00955-x
Kulczyńska-Przybik A, Dulewicz M, Doroszkiewicz J, Borawska R, Litman-Zawadzka A, Arslan D, Kułakowska A, Kochanowicz J, Mroczko B (2022) Comparative analysis of neurodegeneration and axonal dysfunction biomarkers in the cerebrospinal fluid of patients with multiple sclerosis. J Clin Med 11:4122. https://doi.org/10.3390/jcm11144122
Article CAS PubMed PubMed Central Google Scholar
van der Vuurst de Vries RM, Wong YYM, Mescheriakova JY, van Pelt ED, Runia TF, Jafari N, Siepman TAM, Melief MJ, Wierenga-Wolf AF, van Luijn MM, Samijn JP, Neuteboom RF, Hintzen RQ (2019) High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome. Mult Scler J 25:958–967. https://doi.org/10.1177/1352458518775303
Olesen MN, Soelberg K, Debrabant B, Nilsson AC, Lillevang ST, Grauslund J, Brandslund I, Madsen JS, Paul F, Smith TJ, Jarius S, Asgari N (2019) Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study. J Neuroinflamm 16:1–12. https://doi.org/10.1186/s12974-019-1440-5
Khalil M, Enzinger C, Langkammer C, Ropele S, Mader A, Trentini A, Vane MLG, Wallner-Blazek M, Bachmaier G, Archelos JJ, Koel-Simmelink MJA, Blankenstein MA, Fuchs S, Fazekas F, Teunissen CE (2013) CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome. Mult Scler J 19:436–442. https://doi.org/10.1177/1352458512458010
Teunissen CE, Iacobaeus E, Khademi M, Brundin L, Norgren N, Koel-Simmelink MJA, Schepens M, Bouwman F, Twaalfhoven HAM, Blom HJ, Jakobs C, Dijkstra CD (2009) Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis. Neurology 72:1322–1329. https://doi.org/10.1212/WNL.0b013e3181a0fe3f
Article CAS PubMed Google Scholar
Fialová L, Bartos A, Švarcová J, Zimova D, Kotoucova J, Malbohan I (2013) Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis. J Neuroimmunol 262:113–120. https://doi.org/10.1016/j.jneuroim.2013.06.010
Article CAS PubMed Google Scholar
Avsar T, Korkmaz D, Tütüncü M, Demirci NO, Saip S, Kamasak M, Siva A, Turanli ET (2012) Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis. Mult Scler J 18:1081–1091. https://doi.org/10.1177/1352458511433303
Novakova L, Axelsson M, Malmeström C, Imberg H, Elias O, Zetterberg H, Nerman O, Lycke J (2018) Searching for neurodegeneration in multiple sclerosis at clinical onset: diagnostic value of biomarkers. PLoS One 13:1–14. https://doi.org/10.1371/journal.pone.0194828
Martínez MAM, Olsson B, Bau L, Matas E, Calvo ÁC, Andreasson U, Blennow K, Romero-Pinel L, Martínez-Yélamos S, Zetterberg H (2015) Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis. Mult Scler J 21:550–561
Modvig S, Degn M, Roed H, Sørensen TL, Larsson HBW, Langkilde AR, Frederiksen JL, Sellebjerg F (2015) Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis. Mult Scler 21:1761–1770
Article CAS PubMed Google Scholar
Arrambide G, Espejo C, Eixarch H, Villar LM, Alvarez-Cermeño JC, Picón C, Kuhle J, Disanto G, Kappos L, Sastre-Garriga J, Pareto D, Simon E, Comabella M, Río J, Nos C, Tur C, Castilló J, Vidal-Jordana A, Galán I, Arévalo MJ, Auger C, Rovira A, Montalban X, Tintore M (2016) Neurofilament light chain level is a weak risk factor for the development of MS. Neurology 87:1076–1084. https://doi.org/10.1212/WNL.0000000000003085
Article CAS PubMed PubMed Central Google Scholar
Håkansson I, Tisell A, Cassel P, Blennow K, Zetterberg H, Lundberg P, Dahle C, Vrethem M, Ernerudh J (2017) Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing–remitting multiple sclerosis. Eur J Neurol 24:703–712. https://doi.org/10.1111/ene.13274
Bittner S, Steffen F, Uphaus T, Muthuraman M, Fleischer V, Salmen A, Luessi F, Berthele A, Klotz L, Meuth SG, Bayas A, Paul F, Hartung HP, Linker R, Heesen C, Stangel M, Wildemann B, Then Bergh F, Tackenberg B, Kuempfel T, Weber F, Zettl UK, Ziemann U, Tumani H, Groppa S, Mühlau M, Lukas C, Hemmer B, Wiendl H, Gold R, Zipp F (2020) Clinical implications of serum neurofilament in newly diagnosed MS patients: a longitudinal multicentre cohort study. EBioMedicine. https://doi.org/10.1016/j.ebiom.2020.102807
Article PubMed PubMed Central Google Scholar
R Core Team (2021) R: a language and environment for statistical computing
Wickham H, Bryan J (2023) readxl: read excel files. R package version 143
Wickham H, François R, Henry L, Müller K, Vaughan D (2023) dplyr: a grammar of data manipulation. R package version 114
Rich B (2023) table1: tables of descriptive statistics in HTML. R package version 143
Wickham H (2016) ggplot2: elegant graphics for data analysis
Kassambara A (2023) ggpubr: “ggplot2” based publication ready plots. R package version 060
Turck N, Vutskits L, Sanchez-Pena P, Robin X, Hainard A, Gex-Fabry M, Fouda C, Bassem H, Mueller M, Lisacek F, Puybasset L, Sanchez J-C (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 8:12–77
Petzold A, Fraser CL, Abegg M, Alroughani R, Alshowaeir D, Alvarenga R, Andris C, Asgari N, Barnett Y, Battistella R, Behbehani R, Berger T, Bikbov MM, Biotti D, Biousse V, Boschi A, Brazdil M, Brezhnev A, Calabresi PA, Cordonnier M, Costello F, Cruz FM, Cunha LP, Daoudi S, Deschamps R, de Seze J, Diem R, Etemadifar M, Flores-Rivera J, Fonseca P, Frederiksen J, Frohman E, Frohman T, Tilikete CF, Fujihara K, Gálvez A, Gouider R, Gracia F, Grigoriadis N, Guajardo JM, Habek M, Hawlina M, Martínez-Lapiscina EH, Hooker J, Hor JY, Howlett W, Huang-Link Y, Idrissova Z, Illes Z, Jancic J, Jindahra P, Karussis D, Kerty E, Kim HJ, Lagrèze W, Leocani L, Levin N, Liskova P, Liu Y, Maiga Y, Marignier R, McGuigan C, Meira D, Merle H, Monteiro MLR, Moodley A, Moura F, Muñoz S, Mustafa S, Nakashima I, Noval S, Oehninger C, Ogun O, Omoti A, Pandit L, Paul F, Rebolleda G, Reddel S, Rejdak K, Rejdak R, Rodriguez-Morales AJ, Rougier MB, Sa MJ, Sanchez-Dalmau B, Saylor D, Shatriah I, Siva A, Stiebel-Kalish H, Szatmary G, Ta L, Tenembaum S, Tran H, Trufanov Y, van Pesch V, Wang AG, Wattjes MP, Willoughby E, Zakaria M, Zvornicanin J, Balcer L, Plant GT (2022) Diagnosis and classification of optic neuritis. Lancet Neurol 21:1120–1134. https://doi.org/10.1016/S1474-4422(22)00200-9
Modvig S, Degn M, Sander B, Horwitz H, Wanscher B, Sellebjerg F, Frederiksen JL (2016) Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis. Mult Scler 22:590–598. https://doi.org/10.1177/1352458515599074
Article CAS PubMed Google Scholar
Bridel C, Van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landén M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, Pérez-Santiago J, Piehl F, Pijnenburg YAL, Pyykkö OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillbäck T, Stilund M, Sundström P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, Van Swieten JC, Vågberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelsø C, Wild EJ (2019) Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol 76:1035–1048. https://doi.org/10.1001/jamaneurol.2019.1534
留言 (0)